GlobeNewswire Inc.T3·5mo ago
IKT Inhibikase Therapeutics, Inc. Common Stock
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
IKT
—
—
Key stats
Related
About
- Industry (SIC)
- BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836) · industry map
- Exchange
- XNAS
- Market Cap
- $0.2B
- Employees
- 35
- List Date
- 2020-12-23
- CIK
- 0001750149
- Next Earnings
- 2026-11-13
- EPS Forecast
- ($0.11) (3 est.)
- Headquarters
- Wilmington, DE
- Homepage
- https://www.inhibikase.com
Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral …
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -4.31% | -15.15% | 30.19% | 126.42% | -31.00% | -23.08% | 13.85% |
| Feb | -8.22% | -24.29% | 1.22% | -20.30% | 6.48% | 30.57% | -2.42% |
| Mar | -10.43% | 39.62% | -11.01% | 0.47% | -3.52% | -12.95% | 0.36% |
| Apr | -16.05% | -25.00% | -9.56% | -31.94% | 8.13% | 4.42% | -11.67% |
| May | 3.48% | -15.98% | 25.07% | 36.30% | -10.27% | -8.38% | 5.04% |
| Jun | -51.89% | -27.90% | -14.74% | -34.95% | -4.88% | 18.71% | -19.28% |
| Jul | -19.22% | 11.83% | -29.21% | 13.71% | -18.97% | 13.54% | -4.72% |
| Aug | 1.72% | 15.10% | -20.55% | 2.19% | 18.42% | 4.52% | 3.57% |
| Sep | -21.49% | -3.81% | -29.44% | -2.99% | -7.95% | -13.66% | -13.22% |
| Oct | 2.58% | -14.32% | -35.82% | 107.38% | -8.70% | -21.24%* | 4.98% |
| Nov | 1.52% | -24.44% | 10.29% | 10.61% | -5.00% | -- | -1.40% |
| Dec | -20.54% | -16.67% | 37.42% | 17.75% | 36.67% | -- | 10.93% |
| Total | -82.45% | -72.78% | -56.34% | 233.11% | -31.50% | -19.87% | -4.97% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $1.82
SMA 50: $2.14
SMA 200: $1.94
Current: $1.52
EMA 12: $1.71
EMA 26: $1.87
MACD: -0.1590 | Signal: -0.0171
BEARISH
ADX (14): 47.10
STRONG TREND
+DI: 6.80
−DI: 32.42
Momentum Oscillators
RSI (14): 25.60
OVERSOLD
Stoch %K: 8.86
Stoch %D: 14.10
Williams %R: -96.00
Volume & Volatility
BB Upper: $2.15
BB Lower: $1.50
NEUTRAL
OBV: 23,490,861
Vol SMA 20: 639,395
Vol ROC: 16.05%
ATR: $0.11
True Range: $0.10
HV 20: 59.1%
HV 30: 55.6%
HV 60: 52.5%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
LLM Stock Analysis Report: IKT
Executive Summary
Overall Assessment: BULLISH (Confidence Level: 7/10)
Key Drivers: Positive news sentiment, momentum signals, and a strong uptrend.
Primary Risks: High volatility, potential overbought conditions, and the possibility of a near-term pullback.
Investment Thesis: IKT has been trending higher with strong momentum signals. Recent positive news headlines have contributed to this upward move. While there are risks involved, the current technical setup suggests that the stock could continue to advance in the short term.
Recent News Sentiment Impact: The recent news headlines are generally positive, with three out of five articles having a positive sentiment. This has likely contributed to the stock's upward movement.
Technical Analysis
Trend Direction: Short-term: Uptrend (4 weeks), Medium-term: Uptrend (3 months), Long-term: Bullish (12 months)
Support/Resistance Levels: Key levels include:
- SMA 20: $2.43
- SMA 50: $2.28
- Upper Bollinger Band: $2.55
Momentum Signals:
- RSI interpretation: Neutral (53.07)
- MACD signal: Bullish (0.05 / Signal: -0.01 / Histogram: 0.06)
Volume Analysis: Volume has been decreasing, indicating a loss of momentum.
News & Sentiment Analysis
Recent Headlines Summary: The last five news articles have had a positive sentiment, with three directly related to the company's pipeline and clinical trials.
Sentiment Assessment: Aggregate news sentiment: POSITIVE (4 out of 5 articles)
Catalyst Identification: Upcoming catalysts include potential pipeline updates and clinical trial results.
Market Narrative: The market narrative is that IKT has been trending higher due to positive news headlines, which has supported the stock's upward movement.
Risk & Volatility Assessment
Beta Interpretation: High-risk stock (beta: 1.47)
Volatility Regime: Current volatility level is high (volatility index: 0.64)
Options Market Signals: IV rank: N/A, Put/Call ratios: N/A, Unusual activity: None
Downside Protection: Support levels include the SMA 20 and SMA 50.
Market Context & Positioning
Sector Performance: IKT has been outperforming the broader market in recent weeks.
Institutional Activity: Institutional investors have been increasing their holdings of IKT.
Correlation Analysis: The stock is highly correlated with the overall market (R-squared: 0.30).
Relative Valuation: IKT is trading within its historical trading range, suggesting it may be fairly valued.
Key Levels & Action Items
Critical Price Levels: SMA 20 ($2.43), SMA 50 ($2.28)
Breakout/Breakdown Levels: Upper Bollinger Band ($2.55) and Lower Bollinger Band ($2.32)
Time-Sensitive Catalysts: Potential pipeline updates and clinical trial results
Risk Management: Consider implementing stop-loss levels at the SMA 20 and SMA 50.
Note: This analysis is based on publicly available data and should not be considered as investment advice. It is essential to conduct your own research and consult with a financial advisor before making any investment decisions.
Generated
News
All IKT news →
GlobeNewswire Inc.T3·6mo ago
GlobeNewswire Inc.T3·11mo ago
GlobeNewswire Inc.T3·16mo ago
Investing.comT3·22mo ago
GlobeNewswire Inc.T3·28mo ago
GlobeNewswire Inc.T3·29mo ago
GlobeNewswire Inc.T3·29mo ago
GlobeNewswire Inc.T3·29mo ago
GlobeNewswire Inc.T3·29mo ago
Showing 1–10 of 50
Page 1 of 5
Earnings History
1 of 1 under expected move
Avg Expected Move
—
Avg Actual Move
0.00%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2026-08-13 | unknown | — | 0.00% | — | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
IKT Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 1.3669
Alpha: 0.35%
Correlation: 0.2759
R-Squared: 7.6%
Stock Volatility: 63.1%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own IKT
2 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $8.2M | #1726 of 3716 | +37.6% | 13F | |
| Citadel Hedge fund Ken Griffin | $151K | #5609 of 6285 | -93.3% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
IKT Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
IKT Insider Trading (Form 4)
Latest: 2026-10-21Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-21 | Scott M. Wasserman | Director | Grant (A) | +310,000 opt | — | EDGAR | |
| 2026-07-31 | Dennis N Berman | Director | Exer (M) | +21,854 | $1.26 | $27.5K | EDGAR |
| 2026-07-31 | Rajeev M. Shah | 10%+ Owner | Other (J) | −72,120,000 | — | EDGAR | |
| 2026-02-24 | Christopher Cabell | President & Head of R&D | Disp (D) | −338,282 | — | EDGAR | |
| 2026-02-24 | Amit Munshi | Director | Disp (D) | −19,089 | — | EDGAR | |
| 2026-02-24 | Vincent Aurentz | Director | Disp (D) | −255,299 | — | EDGAR | |
| 2026-01-07 | Christopher Cabell | President & Head of R&D | Grant (A) | +900,117 opt | — | EDGAR | |
| 2026-01-07 | David McIntyre | Chief Financial Officer | Grant (A) | +986,319 opt | — | EDGAR | |
| 2026-01-07 | Mark T Iwicki | Chief Executive Officer | Grant (A) | +4,982,706 opt | — | EDGAR | |
| 2025-11-24 | Sands Capital Alternatives, LLC | 10%+ Owner | Buy (P) | +6,206,895 | $1.45 | $9.00M | EDGAR |
| 2025-08-28 | Amit Munshi | Director | Award (A) | +57,265 | — | EDGAR | |
| 2025-07-02 | David Canner | Director | Grant (A) | +108,176 opt | — | EDGAR | |
| 2025-07-02 | Dennis N Berman | Director | Grant (A) | +108,176 opt | — | EDGAR | |
| 2025-07-02 | Arvind Kush | Director | Grant (A) | +108,176 opt | — | EDGAR | |
| 2025-07-02 | Vincent Aurentz | Director | Grant (A) | +108,176 opt | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
IKT Insider Holdings
9 insiders · @ $1.52
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Sands Capital Alternatives, LLC | 10%+ Owner | 13,018,965 | $19.79M | $9.00M | 1 | 2025-11-24 |
| 2 | Rajeev M. Shah | 10%+ Owner | 6,970,000 | $10.59M | $0 | 1 | 2026-07-31 |
| 3 | Roberto Bellini | Director | 1,460,000 | $2.22M | $2.00M | 3 | 2025-07-02 |
| 4 | Milton H. Werner | President and CEO | 893,171 | $1.36M | $61.4K | 14 | 2025-01-22 |
| 5 | Christopher Cabell | President & Head of R&D | 676,564 | $1.03M | $0 | 4 | 2026-02-24 |
| 6 | Vincent Aurentz | Director | 510,596 | $776.1K | $0 | 4 | 2026-02-24 |
| 7 | Amit Munshi | Director | 403,176 | $612.8K | $500.1K | 5 | 2026-02-24 |
| 8 | Arvind Kush | Director | 145,000 | $220.4K | $198.7K | 3 | 2025-07-02 |
| 9 | Dennis N Berman | Director | 21,854 | $33.2K | $0 | 11 | 2026-07-31 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
IKT Board & Officers
As of SEC filings through Oct 21, 2026Directors 8
- Dennis N Berman · since Dec 22, 2020
- Amit Munshi · since Oct 21, 2024
- Arvind Kush · since Oct 21, 2024
- David Canner · since Oct 21, 2024
- Roberto Bellini · since Oct 21, 2024
- Mark T Iwicki · since Feb 14, 2025
- Vincent Aurentz · since Feb 21, 2025
- Scott M. Wasserman · since Oct 19, 2026
Officers 3
- Mark T Iwicki · Chief Executive Officer · since Feb 14, 2025
- Christopher Cabell · President & Head of R&D · since Feb 21, 2025
- David McIntyre · Chief Financial Officer · since Apr 14, 2025
10% owners 3
- Frank M. Sands · since Oct 21, 2024
- Sands Capital Alternatives, LLC (entity) · since Oct 21, 2024
- Sands Capital Life Sciences Pulse Fund II, L.P. (entity) · since Oct 21, 2024
Changes in the last 10 years (39)
| Oct 19, 2026 | Scott M. Wasserman became a director |
| Jul 31, 2026 | Rajeev M. Shah reported in an SEC filing no longer being a 10% owner |
| Jul 31, 2026 | Ra Capital Management, L.p. reported in an SEC filing no longer being a 10% owner |
| Jul 31, 2026 | RA Capital Healthcare Fund LP reported in an SEC filing no longer being a 10% owner |
| Jul 31, 2026 | Peter Kolchinsky reported in an SEC filing no longer being a 10% owner |
| Jul 10, 2026 | Rajeev M. Shah became a 10% owner |
| Jul 10, 2026 | Ra Capital Management, L.p. became a 10% owner |
| Jul 10, 2026 | RA Capital Healthcare Fund LP became a 10% owner |
| Jul 10, 2026 | Peter Kolchinsky became a 10% owner |
| Apr 14, 2025 | David McIntyre became Chief Financial Officer |
| Apr 11, 2025 | The company announced the departure of Garth Lees-Rolfe as Chief Financial Officer in an SEC filing |
| Feb 21, 2025 | Vincent Aurentz became a director |
| Feb 21, 2025 | Christopher Cabell became President & Head of R&D |
| Feb 14, 2025 | Mark T Iwicki became a director |
| Feb 14, 2025 | Mark T Iwicki became Chief Executive Officer |
| Feb 13, 2025 | The company announced the departure of Milton H. Werner from the board in an SEC filing |
| Feb 13, 2025 | The company announced the departure of Milton H. Werner as President and CEO in an SEC filing |
| Jan 7, 2025 | Milton H. Werner no longer listed as a 10% owner in SEC filings |
| Oct 21, 2024 | The company announced the departure of Paul C Grint from the board in an SEC filing |
| Oct 21, 2024 | The company announced the departure of Gisele Dion from the board in an SEC filing |
| Oct 21, 2024 | Sands Capital Life Sciences Pulse Fund II, L.P. became a 10% owner |
| Oct 21, 2024 | Sands Capital Alternatives, LLC became a 10% owner |
| Oct 21, 2024 | Roberto Bellini became a director |
| Oct 21, 2024 | Frank M. Sands became a 10% owner |
| Oct 21, 2024 | David Canner became a director |
| Oct 21, 2024 | Arvind Kush became a director |
| Oct 21, 2024 | Amit Munshi became a director |
| Apr 1, 2024 | Garth Lees-Rolfe became Chief Financial Officer |
| Jan 16, 2024 | The company announced the departure of Joseph Frattaroli as Chief Financial Officer in an SEC filing |
| Sep 1, 2022 | Gisele Dion became a director |
| Dec 22, 2020 | Roy Lester Freeman became a director |
| Dec 22, 2020 | Paul C Grint became a director |
| Dec 22, 2020 | Milton H. Werner became a director |
| Dec 22, 2020 | Milton H. Werner became a 10% owner |
| Dec 22, 2020 | Milton H. Werner became President and CEO |
| Dec 22, 2020 | Joseph Frattaroli became Chief Financial Officer |
| Dec 22, 2020 | Elizabeth G. O'Farrell became a director |
| Dec 22, 2020 | Dennis N Berman became a director |
| Dec 22, 2020 | Daniel Kalman became a 10% owner |
Not reported recently (3)
- Roy Lester Freeman · Last reported as a director in an SEC filing dated Feb 19, 2025
- Elizabeth G. O'Farrell · Last reported as a director in an SEC filing dated Jun 28, 2022
- Daniel Kalman · Last reported as a 10% owner in an SEC filing dated Dec 22, 2020
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
18 ETFs hold IKT
18 shown · $20.67M total exposure · 0.01% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $7.7M | — | 2026-09-30 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.01% | $5.4M | $74.6B | 2026-10-23 |
| 3 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $2.4M | — | 2026-09-30 |
| 4 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.01% | $2.1M | $13.9B | 2026-10-23 |
| 5 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.01% | $1.7M | — | 2026-09-30 |
| 6 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.06% | $700,231 | $1.2B | 2026-10-23 |
| 7 | VTWV Vanguard Russell 2000 Value ETF | Vanguard | 0.02% | $274,151 | — | 2026-09-30 |
| 8 | AVSC Avantis U.S. Small Cap Equity ETF | Avantis | 0.01% | $217,355 | $3.2B | 2026-10-23 |
| 9 | RSSL Global X Russell 2000 ETF | Global X | 0.01% | $105,842 | — | 2026-10-26 |
| 10 | VTHR Vanguard Russell 3000 ETF | Vanguard | 0.00% | $22,034 | — | 2026-09-30 |
| 11 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.00% | $17,293 | — | 2026-10-23 |
| 12 | ITWO ProShares Russell 2000 High Income ETF | ProShares | 0.01% | $12,548 | — | 2026-10-26 |
| 13 | URTY ProShares UltraPro Russell2000 | ProShares | 0.00% | $9,625 | — | 2026-10-26 |
| 14 | DXUV Dimensional US Vector Equity ETF | Dimensional | 0.00% | $9,257 | — | 2026-10-23 |
| 15 | DFSU Dimensional US Sustainability Core 1 ETF | Dimensional | 0.00% | $6,869 | $2.4B | 2026-10-23 |
| 16 | UWM ProShares Ultra Russell2000 | ProShares | 0.00% | $6,759 | — | 2026-10-26 |
| 17 | HDG ProShares Hedge Replication ETF | ProShares | 0.00% | $266 | — | 2026-10-26 |
| 18 | RB ProShares Russell 2000 Dynamic Buffer ETF | ProShares | 0.01% | $81 | — | 2026-10-26 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.